Updated:
Sansei Capital Investment
Sansei Capital Investment is a venture capital firm headquartered in Tokyo, Japan, and a subsidiary of Taiju Life Insurance. The firm manages $104 million in...
Overview
Sansei Capital Investment is a venture capital firm headquartered in Tokyo, Japan, and a subsidiary of Taiju Life Insurance. The firm manages $104 million in assets under management. Sansei Capital has made 59 investments to date, demonstrating active deployment across venture-stage opportunities. Notable investments include a Series A round in RABO completed on April 6, 2021. The firm has achieved 17 portfolio exits, including J-Pharma, which exited on March 25, 2026. Through its relationship with Taiju Life Insurance, Sansei Capital leverages corporate backing to support its venture investment activities. The firm's track record reflects engagement across multiple stages of venture funding.
General information
Firm type
Venture Capital
AUM
$104 million
Location
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Sector focus
Frequently asked questions
What is Sansei Capital Investment?
Sansei Capital Investment is a venture capital subsidiary of Taiju Life Insurance, headquartered in Tokyo, Japan, with $104 million in assets under management.
How many investments has Sansei Capital made?
Sansei Capital has made 59 investments, including a Series A investment in RABO on April 6, 2021.
How many exits does Sansei Capital have?
Sansei Capital has completed 17 portfolio exits, including J-Pharma, which exited on March 25, 2026.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: